CAS: 1128-61-6; 6-Fluoro-2-Methylquinoline

该化合物是环环环有机化合物,其特点是一条基质脊椎,由一条引信苯和环组成;六点方位有氟原子,二点有甲基组,其独特的化学特性是氟原子的出现;该化合物一般是黄到褐的固体,以其芳香性质而闻名,具有稳定性和影响其再活性;在有机溶剂和水溶液中具有中度溶性;6-Fluoro-2-甲基基尼线,因其潜在的生物活动,包括抗微生物和抗舌性,对包括医药化学在内的各个领域都感兴趣;其结构允许与生物目标互动,使其成为药物开发的候选物;此外,氟亚基质可增强脂性并具有合金稳定性,这是药物应用中的适当特性;在处理和接触风险时,应参考安全数据,如任何化学物质一样.

结构式图片

相似化合物

1128-74-1 46001-36-9 1128-74-1

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号877-42-9 6-溴-2-甲基喹啉 | CAS号199186-69-1 (R)-6-FLUORO-2-... | CAS号75-07-0 乙醛 | CAS号371-40-4 4-氟苯胺 | CAS号42835-89-2 6-氟-1,2,3,4-四氢-... | CAS号64-17-5 乙醇 | CAS号109-92-2 乙烯基乙醚 | CAS号123-73-9 2-丁烯醛 | CAS号350-46-9 对氟硝基苯 | CAS号42835-89-2 6-氟-1,2,3,4-四氢-... | CAS号143703-35-9 6-fluoro-2,5-di... | CAS号91-63-4 2-甲基喹啉 | CAS号1220450-27-0 2-methyl-6-(4-t... | CAS号260430-93-1 6-氟喹啉-2-甲醛 | CAS号124858-35-1 那氟沙星 | CAS号124050-15-3 2-(chloromethyl... | CAS号199186-69-1 (R)-6-FLUORO-2-... | CAS号199186-68-0 (S)-6-FLUORO-2-... | CAS号80290-18-2 5-溴-6-氟-2-甲基喹啉

合成工艺路线路线简述

  • 合成目标产物 6-Fluoroquinaldine 主要起始原料 Ethanol And 4-Fluoroaniline
  • (文献来源)合成步骤主要原料 Ethanol 和 4-Fluoroaniline
(R)-6-Fluoro-2-Methyl-1,2,3,4-Tetrahydroquinoline置于cobalt(II) Acetate Air,丙酸,Sodium Bromide体系中,120.0~140.0 °C,800.0 Kpa 条件下,反应 8.0H,反应生成6-氟-2-甲基喹啉
参考文献:Unusual Phenomena During The Resolution Of 6-Fluoro-2-Methyl-1,2,3,4-Tetrahydroquinoline (Fthq): Thermodynamic-Kinetic Control
标题:Unusual Phenomena During The Resolution Of 6-Fluoro-2-Methyl-1,2,3,4-Tetrahydroquinoline (Fthq): Thermodynamic-Kinetic Control
摘要:6-Fluoro-2-Methyl-1,2,3,4-Tetrahydroquinoline (Fthq) Was Resolved In Several Different Solvents By Tartaric Acid Derivatives As The Most Common Acidic Resolving Agents Available In Industrial Quantities. Strong Reaction Kinetics And Solvent Dependence Were Observed,Curiously Without Solvation. In Possession Of These Findings,An Economic Resolution Process Is Proposed,Which Is Completed By The Incorporation Of A Racemization Step. (C)C 2002 Elsevier Science Ltd. All Rights Reserved.
Doi:10.1016/s0957-4166(02)00021-6

海关参考信息

专利信息


专利号:US-11795168-B2
优先权日:2020-09-23
标 题:Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
发明人:LUKE GEORGE; BABU SURESH
权利人:FORMA THERAPEUTICS INC
摘要:The present disclosure is directed to solid and salt forms of inhibitors of the CBP/p300 family of bromodomains made up of salts and crystalline forms of Formula (I). The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains (e.g., certain forms of cancer), and methods of synthesis of these compounds.

专利号:US-12378242-B2
优先权日:2018-06-29
标题 :Inhibiting CREB binding protein (CBP)
发明人:SCHILLER SHAWN E R; HERBERTZ TORSTEN; LI HONGBIN; GRAVES BRADFORD; MISCHKE STEVEN; WEST Angela; DOWNING JENNIFER R; ERICSSON ANNA
权利人:FORMA THERAPEUTICS INC
摘要:The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains, and methods of synthesis of these compounds.

专利号:US-11787803-B2
优先权日:2017-09-15
标 题 :Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
发明人:SCHILLER SHAWN E R; HERBERTZ TORSTEN; LI HONGBIN; GRAVES BRADFORD; MISCHKE STEVEN; WEST ANGELA V; DOWNING JENNIFER R; ERICSSON ANNA
权利人:FORMA THERAPEUTICS INC
摘要:The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains, and methods of synthesis of these compounds.

专利号:JP-H07300461-A
优先权日:1986-01-22
标题 :Intermediate for synthesis of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H, 5H-benzo [i, j] quinolizine-2-carboxylic acid and process for producing the same

专利号:JP-H0759579-B2
优先权日:1986-01-22
标题:Synthesis of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H, 5H-benzo [i, j] quinolizine-2-carboxylic acid

专利号:JP-S62201888-A
优先权日:1986-01-22
标题:Synthesis of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolidine-2-carboxylic acid
友顺精细化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.usunfc.com
企业联系电话:025-84574075;84574691👤
📞友顺精细化工有限公司 ⚠️参考联系方式
联系人:销售部
电话:025-84574075;84574691

传真:025-84574930
邮箱:sales@usunfc.com
通信地址: 南京市建邺区云龙山路89号龙湖时代上城1栋1005室
邮编: 210019
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:南京市建邺区云龙山路89号龙湖时代上城1栋1005室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Sharma, U.; Kumar, R.; Gupta, S. S.; Chandra, D., Science of Synthesis Knowledge Updates, (2022) 2, 242.
摘要:Sharma, U.; Kumar, R.; Gupta, S. S.; Chandra, D., Science of Synthesis Knowledge Updates, (2022) 2, 175.
摘要:Lu, S.-M.; Zhou, Y.-G., Science of Synthesis: Stereoselective Synthesis, (2011) 1, 269.
摘要:Xu, L.; Wu, X.; Xiao, J., Science of Synthesis: Stereoselective Synthesis, (2011) 2, 274.
摘要:García-García, P., Science of Synthesis: Asymmetric Organocatalysis, (2012) 1, 865.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知